GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Rácz, Emoke ^a   Kurek, Dorota ^a   Kant, Marius ^a   Baerveldt, Ewout M ^a   Florencia, Edwin ^a   Mourits, Sabine ^a   de Ridder, Dick ^b   Laman, Jon D ^a   van der Fits, Leslie ^a   Prens, Errol P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Delft University of Technology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; INTERLEUKIN 4; TRANSCRIPTION FACTOR GATA 3;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; EPIDERMIS; FEMALE; GATA3 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; JAGGED GENE; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PSORIASIS; SKIN BIOPSY; TISSUE REGENERATION; TRANSCRIPTION FACTOR AP2 GENE; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3 GENE; ULTRAVIOLET B RADIATION; WOUND HEALING; ANIMAL; CELL CYCLE; CELL NUCLEUS; DERMATITIS; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOTOTHERAPY; PROTEIN TRANSPORT; RADIATION EXPOSURE; REGENERATION; ULTRAVIOLET RADIATION; UPREGULATION;

MUS;

ADULT; AGED; ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; DERMATITIS; EPIDERMIS; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-4; KERATINOCYTES; MALE; MICE; MIDDLE AGED; PHOTOTHERAPY; PROTEIN TRANSPORT; PSORIASIS; REGENERATION; ULTRAVIOLET RAYS; UP-REGULATION; YOUNG ADULT;

EID: 79956066788     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019806     Document Type: Article

References (49)

1. Tschachler E, (2007) Psoriasis: the epidermal component. Clin Dermatol 25: 589-595.
2. Ghadially R, Reed JT, Elias PM, (1996) Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 107: 558-564.
3. Haider AS, Peters SB, Kaporis H, Cardinale I, Fei J, et al. (2006) Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 126: 869-881.
4. Oestreicher JL, Walters IB, Kikuchi T, Gilleaudeau P, Surette J, et al. (2001) Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 1: 272-287.
5. Rácz E, Prens E, Kurek D, Kant M, de Ridder D, et al. (2011) Effective Treatment of Psoriasis with Narrow-Band UVB Phototherapy Is Linked to Suppression of the IFN and Th17 Pathways. J Invest Dermatol.
6. Yamamoto M, Ko LJ, Leonard MW, Beug H, Orkin SH, et al. (1990) Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev 4: 1650-1662.
7. Chikh A, Sayan E, Thibaut S, Lena AM, DiGiorgi S, et al. (2007) Expression of GATA-3 in epidermis and hair follicle: relationship to p63. Biochem Biophys Res Commun 361: 1-6.
8. Kaufman CK, Zhou P, Pasolli HA, Rendl M, Bolotin D, et al. (2003) GATA-3: an unexpected regulator of cell lineage determination in skin. Genes Dev 17: 2108-2122.
9. Kurek D, Garinis GA, van Doorninck JH, van der Wees J, Grosveld FG, (2007) Transcriptome and phenotypic analysis reveals Gata3-dependent signalling pathways in murine hair follicles. Development 134: 261-272.
10. de Guzman Strong C, Wertz PW, Wang C, Yang F, Meltzer PS, et al. (2006) Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3. J Cell Biol 175: 661-670.
11. Son do N, Li L, Katsuyama H, Komatsu N, Saito M, et al. (2009) Abundant expression of Kallikrein 1 gene in human keratinocytes was mediated by GATA3. Gene 436: 121-127.
12. George KM, Leonard MW, Roth ME, Lieuw KH, Kioussis D, et al. (1994) Embryonic expression and cloning of the murine GATA-3 gene. Development 120: 2673-2686.
13. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, et al. (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet 11: 40-44.
14. van der Wees J, van Looij MA, de Ruiter MM, Elias H, van der Burg H, et al. (2004) Hearing loss following Gata3 haploinsufficiency is caused by cochlear disorder. Neurobiol Dis 16: 169-178.
15. Oosterwegel M, Timmerman J, Leiden J, Clevers H, (1992) Expression of GATA-3 during lymphocyte differentiation and mouse embryogenesis. Dev Immunol 3: 1-11.
16. Schwarz BA, Bhandoola A, (2006) Trafficking from the bone marrow to the thymus: a prerequisite for thymopoiesis. Immunol Rev 209: 47-57.
17. Zheng W, Flavell RA, (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596.
18. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A, (1997) Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 272: 21597-21603.
19. Ouyang W, Lohning M, Gao Z, Assenmacher M, Ranganath S, et al. (2000) Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12: 27-37.
20. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, et al. (1998) Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9: 745-755.
21. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, et al. (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41: 199-204.
22. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182: 5836-5845.
23. Nickoloff BJ, Bonish BK, Marble DJ, Schriedel KA, DiPietro LA, et al. (2006) Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammation. J Investig Dermatol Symp Proc 11: 16-29.
24. Breternitz M, Flach M, Prassler J, Elsner P, Fluhr JW, (2007) Acute barrier disruption by adhesive tapes is influenced by pressure, time and anatomical location: integrity and cohesion assessed by sequential tape stripping. A randomized, controlled study. Br J Dermatol 156: 231-240.
25. Bashir SJ, Chew AL, Anigbogu A, Dreher F, Maibach HI, (2001) Physical and physiological effects of stratum corneum tape stripping. Skin Res Technol 7: 40-48.
26. Loffler H, Dreher F, Maibach HI, (2004) Stratum corneum adhesive tape stripping: influence of anatomical site, application pressure, duration and removal. Br J Dermatol 151: 746-752.
27. Companjen AR, van der Wel LI, Wei L, Laman JD, Prens EP, (2001) A modified ex vivo skin organ culture system for functional studies. Arch Dermatol Res 293: 184-190.
28. Prens EP, Kant M, van Dijk G, van der Wel LI, Mourits S, et al. (2008) IFN-alpha enhances poly-IC responses in human keratinocytes by inducing expression of cytosolic innate RNA receptors: relevance for psoriasis. J Invest Dermatol 128: 932-938.
29. Staal FJ, Weerkamp F, Baert MR, van den Burg CM, van Noort M, et al. (2004) Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion. J Immunol 172: 1099-1108.
30. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
31. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
32. Dik WA, Pike-Overzet K, Weerkamp F, de Ridder D, de Haas EF, et al. (2005) New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med 201: 1715-1723.
33. Ge U, Dudoit S, Speed T, (2003) Resampling-based multiple testing for microarray data analysis. TEST 12: 1-44.
34. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
35. van der Fits L, van der Wel LI, Laman JD, Prens EP, Verschuren MC, (2003) Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2). J Pathol 199: 107-114.
36. Hendriks R, Nawijn M, Engel J, van Doorninck H, Grosveld F, et al. (1999) Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur J Immunol 29: 1912-1918.
37. Coornaert B, Carpentier I, Beyaert R, (2009) A20: central gatekeeper in inflammation and immunity. J Biol Chem 284: 8217-8221.
38. Choi K, Ahn Y, Gibbons D, Tran H, Creighton C, et al. (2009) Distinct biological roles for the notch ligands jagged-1 and jagged-2. J Biol Chem 284: 17766-17774.
39. Fuchs E, Horsley V, (2008) More than one way to skin. Genes and Development 22: 976-985.
40. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, et al. (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202: 135-143.
41. Zhou X, Krueger JG, Kao MC, Lee E, Du F, et al. (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 13: 69-78.
42. Reischl J, Schwenke S, Beekman JM, Mrowietz U, Sturzebecher S, et al. (2007) Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol 127: 163-169.
43. Arshad SH, Karmaus W, Kurukulaaratchy R, Sadeghnejad A, Huebner M, et al. (2008) Polymorphisms in the interleukin 13 and GATA binding protein 3 genes and the development of eczema during childhood. Br J Dermatol 158: 1315-1322.
44. Prens E, Hegmans J, Lien RC, Debets R, Troost R, et al. (1996) Increased expression of interleukin-4 receptors on psoriatic epidermal cells. Am J Pathol 148: 1493-1502.
45. Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, et al. (2003) Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 9: 40-46.
46. Guenova E, Volz T, Sauer K, Kaesler S, Muller MR, et al. (2008) IL-4-mediated fine tuning of IL-12p70 production by human DC. Eur J Immunol 38: 3138-3149.
47. Schuff M, Rössner A, Wacker S, Donow C, Gessert S, et al. (2007) FoxN3 is required for craniofacial and eye development of Xenopus laevis. Dev Dyn 236: 226-239.
48. Gross D, van den Heuvel A, Birnbaum M, (2008) The role of FoxO in the regulation of metabolism. Oncogene 27: 2320-2336.
49. Koon H, Ippolito G, Banham A, Tucker P, (2007) FOXP1: a potential therapeutic target in cancer. Expert Opin Ther Targets 11: 955-965.